Eric Faulkner's most recent trade in Cns Pharmaceuticals Inc was a trade of 9,500 Restricted Stock Units done . Disclosure was reported to the exchange on March 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cns Pharma Inc | Eric Faulkner | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 9,500 | 9,500 | - | - | Restricted Stock Units |